Market Overview:
The global Addison disease testing market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in the market can be attributed to the increasing incidence of Addison disease, rising awareness about the condition, and technological advancements in diagnostic tests. The laboratory testing segment is expected to dominate the global Addison disease testing market during the forecast period. This segment is anticipated to grow at a CAGR of 7.8% from 2018 to 2030 owing to technological advancements that have led to development of new and more accurate diagnostic tests for Addison disease.
Product Definition:
Addison disease testing is a blood test that checks for the presence of antibodies to the adrenal gland. The test is used to help diagnose Addison disease, a condition in which the adrenal gland does not produce enough cortisol.
Laboratory testing:
Laboratory testing is used to diagnose Addison disease. The tests are performed on blood and urine samples. These tests help in determining the level of a certain hormone, called adrenocorticotropic hormone (ACTH), in the patient’s body. High levels of this hormone are found in patients suffering from Addison disease, thus making it easier for doctors to make out the exact cause of illness by performing further diagnostic procedures.
Imaging studies:
Imaging studies and it's usage in Addison disease testing market is a research study which includes MRI, CT scan, X-ray and ultrasound. Imaging studies are used for the diagnosis of diseases by identifying changes in the body tissues. These techniques provide information about the location and severity of damage done to organs. Imaging techniques have been evolving over many years due to technological advancements such as high-resolution CT scanners with 3D capabilities that help doctors determine appropriate dosage for patients undergoing surgery or treatment.
Application Insights:
The clinics segment dominated the global addison disease testing market in 2017. This can be attributed to factors such as rising awareness about the disease and increasing patient visits for diagnosis at outpatient facilities. For instance, according to a study published by NCBI in 2018, around 60% of people with Addison's disease are diagnosed after they have been seen by a doctor three or more times. Thus, increasing number of patients visiting healthcare providers for diagnosis is expected to drive demand over the forecast period.
On the other hand, hospitals accounted for a smaller share owing to various challenges faced during hospital admission such as fluid balance management and electrolyte imbalance correction that may lead to complications in patients suffering from Addison's disease. However, an increase in hospital-based care is anticipated due these advancements that allow easy monitoring of vital signs through electronic health records which will result in increased use of addisonology tests over the forecast period.
Regional Analysis:
North America dominated the global market in 2017. The presence of key players, advanced healthcare infrastructure and high adoption rate for new diagnostic procedures are some of the factors responsible for its large share. Moreover, increasing cases of Addison disease due to a rise in life expectancy and changing lifestyle is anticipated to fuel the regional demand during the forecast period.
Asia Pacific is expected to grow at a lucrative CAGR over the forecast period owing to rising disposable income levels, improving healthcare facilities & infrastructure along with an increase in awareness regarding early diagnosis among patients coupled with rising incidence rates of AD are driving factors responsible for this growth.
In 2016, Japan accounted for maximum revenue share followed by Australia.
Growth Factors:
- Increasing incidence of Addison Disease
- Growing awareness about Addison Disease and its diagnosis
- Rising demand for early diagnosis of Addison Disease
- Technological advancements in the field of Addison Disease testing
- Growing number of collaborations and partnerships between diagnostic companies and research institutes
Scope Of The Report
Report Attributes
Report Details
Report Title
Addison Disease Testing Market Research Report
By Type
Laboratory testing, Imaging studies
By Application
Clinics, Hospitals
By Companies
NHS.UK, Mayo Clinic, VCA Animal Hospital, NIDDK, Cleveland Clinic, WebMD, BMJ Best Practice, National Organization for Rare Disorders, Core Diagnostics Private Limited, Laboratory Corporation of America Holdings, Sonora Quest Laboratories
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
166
Number of Tables & Figures
117
Customization Available
Yes, the report can be customized as per your need.
Global Addison Disease Testing Market Report Segments:
The global Addison Disease Testing market is segmented on the basis of:
Types
Laboratory testing, Imaging studies
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Clinics, Hospitals
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- NHS.UK
- Mayo Clinic
- VCA Animal Hospital
- NIDDK
- Cleveland Clinic
- WebMD
- BMJ Best Practice
- National Organization for Rare Disorders
- Core Diagnostics Private Limited
- Laboratory Corporation of America Holdings
- Sonora Quest Laboratories
Highlights of The Addison Disease Testing Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Laboratory testing
- Imaging studies
- By Application:
- Clinics
- Hospitals
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Addison Disease Testing Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Addison Disease Testing is a blood test used to diagnose Addison Disease.
Some of the major companies in the addison disease testing market are NHS.UK, Mayo Clinic, VCA Animal Hospital, NIDDK, Cleveland Clinic, WebMD, BMJ Best Practice, National Organization for Rare Disorders, Core Diagnostics Private Limited, Laboratory Corporation of America Holdings, Sonora Quest Laboratories.
The addison disease testing market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Addison Disease Testing Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Addison Disease Testing Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Addison Disease Testing Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Addison Disease Testing Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Addison Disease Testing Market Size & Forecast, 2018-2028
4.5.1 Addison Disease Testing Market Size and Y-o-Y Growth
4.5.2 Addison Disease Testing Market Absolute $ Opportunity
Chapter 5 Global Addison Disease Testing Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Addison Disease Testing Market Size Forecast by Type
5.2.1 Laboratory testing
5.2.2 Imaging studies
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Addison Disease Testing Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Addison Disease Testing Market Size Forecast by Applications
6.2.1 Clinics
6.2.2 Hospitals
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Addison Disease Testing Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Addison Disease Testing Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Addison Disease Testing Analysis and Forecast
9.1 Introduction
9.2 North America Addison Disease Testing Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Addison Disease Testing Market Size Forecast by Type
9.6.1 Laboratory testing
9.6.2 Imaging studies
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Addison Disease Testing Market Size Forecast by Applications
9.10.1 Clinics
9.10.2 Hospitals
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Addison Disease Testing Analysis and Forecast
10.1 Introduction
10.2 Europe Addison Disease Testing Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Addison Disease Testing Market Size Forecast by Type
10.6.1 Laboratory testing
10.6.2 Imaging studies
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Addison Disease Testing Market Size Forecast by Applications
10.10.1 Clinics
10.10.2 Hospitals
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Addison Disease Testing Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Addison Disease Testing Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Addison Disease Testing Market Size Forecast by Type
11.6.1 Laboratory testing
11.6.2 Imaging studies
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Addison Disease Testing Market Size Forecast by Applications
11.10.1 Clinics
11.10.2 Hospitals
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Addison Disease Testing Analysis and Forecast
12.1 Introduction
12.2 Latin America Addison Disease Testing Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Addison Disease Testing Market Size Forecast by Type
12.6.1 Laboratory testing
12.6.2 Imaging studies
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Addison Disease Testing Market Size Forecast by Applications
12.10.1 Clinics
12.10.2 Hospitals
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Addison Disease Testing Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Addison Disease Testing Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Addison Disease Testing Market Size Forecast by Type
13.6.1 Laboratory testing
13.6.2 Imaging studies
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Addison Disease Testing Market Size Forecast by Applications
13.10.1 Clinics
13.10.2 Hospitals
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Addison Disease Testing Market: Competitive Dashboard
14.2 Global Addison Disease Testing Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 NHS.UK
14.3.2 Mayo Clinic
14.3.3 VCA Animal Hospital
14.3.4 NIDDK
14.3.5 Cleveland Clinic
14.3.6 WebMD
14.3.7 BMJ Best Practice
14.3.8 National Organization for Rare Disorders
14.3.9 Core Diagnostics Private Limited
14.3.10 Laboratory Corporation of America Holdings
14.3.11 Sonora Quest Laboratories
